Thyrocare Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has informed the stock exchanges that its trading window will be closed from October 1, 2025, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The closure applies to promoters, directors, designated employees, and their immediate relatives, restricting them from trading in the company's shares. The window will reopen 48 hours after the company announces its unaudited financial results for the quarter and half year ended September 30, 2025 (Q2 and H1 FY2026). The Board meeting date to approve these results will be communicated separately. This is a standard regulatory compliance filing and not a company-specific event.
This is a routine compliance intimation and has no direct impact on the stock price or shareholders. It does signal that the company's Q2 FY2026 results are expected in the coming weeks, which investors should watch for.